50 likes | 144 Vues
In-vivo trial results of a novel ultrasonic cough stimulator. Jennifer C. Nitz, PhD, MPhty, BPhty; John Perrier, BPhty; Peter Cook, MBBS, FANZCA, FCICM. Aim Establish: Whether ultrasound (US) stimulation can safely stimulate cough. Most efficient US frequency.
E N D
In-vivo trial results of a novel ultrasonic cough stimulator Jennifer C. Nitz, PhD, MPhty, BPhty; John Perrier, BPhty; Peter Cook, MBBS, FANZCA, FCICM
Aim • Establish: • Whether ultrasound (US) stimulation can safely stimulate cough. • Most efficient US frequency. • Whether single- or dual-sided stimulation is more effective. • Relevance • Ability to cough voluntarily is absent or diminished in many clinical situations, which may predispose patients to or prolong respiratory diseases.
Method • Applied stimulation with CoughStim device to 15 nondisabled and 7 unable-to-cough volunteers: • Unilaterally: 8 frequencies and 2 power levels. • Bilaterally: 2 frequencies and 3 power levels.
Results • Nondisabled subjects • Cough stimulated: • 80% at 0.58 MHz and 9 W unilaterally. • 75% at 0.58 MHz and 6 W bilaterally • Unable-to-cough subjects • Cough stimulated: • 71% at 0.54 MHz and 6 W bilaterally.
Conclusion • CoughStim device: • Regularly and safely produced moderately strong cough response in subjects with or without ability to cough. • Produced this effect without causing undue discomfort.